[1]
K. Ronanki, R. Benson, A. Kacchwaha, and U. K. Nath, “Melasma-like facial hyperpigmentation associated with long-term dasatinib therapy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a rare cutaneous adverse event”, Int J Basic Clin Pharmacol, vol. 15, no. 5, pp. 1035–1038, Aug. 2026.